Searched for
INDIA PHARMACEUTICAL MARKET ACCESS
Groww AMC announces closure of State Street Investment Management’s strategic investmentGroww AMC has completed State Street Investment Management’s strategic investment after receiving all necessary regulatory approvals. State...- India seeks easier pharma access in Brazil, pushes to expand Mercosur trade pactIndia seeks predictable regulations and easier market access for its pharmaceutical products. Discussions occurred at the India-Brazil Trad...
- Why rural healthcare needs India’s entrepreneurs to step inRural healthcare will not be transformed by building more of the same. The next phase will require private companies, entrepreneurs, and te...
- FPIs lobby for faster access to bourses with link to serversThe proposal - put forward by persons representing large offshore funds and custodians at a recent meeting with officials of the Securities...
- India-Uzbekistan ties go comprehensive as Modi, Mirziyoyev set $5 billion trade goalIndia and Uzbekistan elevated their relationship to a Comprehensive Strategic Partnership. They set an ambitious target of five billion dol...
- Argentina to ease pharma barriers as India trade tops $6.5 bnArgentina committed to reducing barriers for Indian pharmaceutical entry. This move will offer greater opportunities for Indian companies a...
- India sees Canada export opening as US trade tensions reshape imports: ReportIndia sees new export chances in Canada as economic ties strengthen. Bilateral trade aims for fifty billion dollars by twenty thirty, with ...
- India sends its Fab 4 across the world to woo trade, tech, energy and capitalIndia engages key partners, focusing on border management and energy security. Discussions with China now include investment alongside boun...
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
- India to seek greater Japan market access for basmati rice in CEPA review:Piyush GoyalIndia will seek greater market access for basmati rice in Japan. The nation also plans to expand processed food exports during trade agreem...
- India-Japan trade could scale to USD 50 bn by 2030 as exports diversify: ASSOCHAMIndia-Japan bilateral trade has the potential to rise to USD 50 billion by 2030 from USD 27.47 billion in 2025-26, with greater export dive...
- Indian companies step up acquisitions for AI, technology and talent: CrisilThe ratings agency said mergers and acquisitions are evolving from an occasional growth option into a core strategic tool for companies see...
- Singapore records over 600,000 Indian visitors in first half of 2026Singapore received over 600,000 Indian visitors in the first half of 2026, while tourism receipts from India rose 8% to S$374 million in Q1...
- 7 debit cards for free airport lounge access: Check fees, visits and eligibility
- Widening trade gap with Japan a concern, Ficci flagsIndia's trade deficit with Japan is a growing concern for local exporters. Indian companies face hurdles accessing the Japanese market due ...
- OfBusiness apparel revenue triples to Rs 3,002 crore in FY26OfBusiness apparel revenue surged to Rs 3,002 crore by fiscal year 2026. This represents a significant increase from Rs 843 crore recorded ...
- DRL, Emcure get approval to make breakthrough HIV drugIndia's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for l...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Delayed, Not Denied: India’s BGAI entry waits on market accessIndia’s potential inclusion in the Bloomberg Global Aggregate Bond Index remains delayed, not denied, with operational accessibility the ke...
- Pharma giant Cipla completes merger with wholly-owned subsidiary Inzpera Health SciencesPharmaceuticals giant Cipla announced its merger with Inzpera Healthsciences Limited on Wednesday. This consolidation aims for more efficie...
Load More
